Company news
Solana Company news in 2024
Solana Company's news releases, calls and decks from 2024, newest first.
Helius Announces First Portable Neuromodulation Stimulator (PoNS®) System Sale to the Veterans Affairs (VA) Healthcare System
December 22, 2024
Helius Medical Technologies, Inc. Provides Updates on Efforts to Achieve Fair Market Access for its Portable Neuromodulation Stimulator (PoNS®) Device
November 17, 2024
Helius Medical Technologies, Inc. Announces Exploration of Strategic Alternatives
November 17, 2024
Helius Medical Technologies, Inc. to Present at the 2024 ThinkEquity Conference
October 17, 2024
Helius Medical Technologies, Inc. Announces Reimbursement Payment Determination Updates from CMS for its Portable Neuromodulation Stimulator (PoNS®) Controller and Mouthpiece
October 13, 2024
Helius Medical Technologies, Inc. Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
August 15, 2024
Helius Medical Technologies, Inc. Reports Second Quarter 2024 Financial Results
August 11, 2024
Helius Medical Technologies, Inc. to Release Second Quarter 2024 Financial Results on August 12, 2024
August 5, 2024
Helius Medical Technologies, Inc. Completes Site Participation Enrollment for its U.S. Registrational Program in Stroke
June 16, 2024
Helius Medical Technologies, Inc. to Present at the Spring MicroCap Rodeo Conference
May 30, 2024
Helius Medical Technologies, Inc. Announces Third-Party Reimbursement for PoNS® from Major Insurance Carrier
May 28, 2024
Helius Medical Technologies to Exhibit at 2024 CMSC Annual Meeting, Marking a Year of Achievements: Making PoNS More Available to People with MS
May 22, 2024
Helius Medical Technologies, Inc. Announces PoNS® Is Now Available on the Veterans Affairs (VA) Federal Supply Schedule (FSS) and General Services Administration (GSA) Advantage Contracts
May 19, 2024
Helius Medical Technologies, Inc. Reports First Quarter 2024 Financial Results
May 12, 2024
Helius Medical Technologies, Inc. to Release First Quarter 2024 Financial Results on May 13, 2024
May 9, 2024
Helius Medical Technologies, Inc. Announces Pricing of $6.4 Million Public Offering
May 5, 2024
Helius Medical Technologies, Inc. Announces Preliminary CMS Payment Determination of Reimbursement for Portable Neuromodulation Stimulator (PoNS®)
May 5, 2024
Helius Medical Technologies, Inc. Expands Stroke Clinical Program with Participation of Shepherd Center
April 23, 2024
Helius Medical Technologies, Inc. Announces Partnership with Lovell® Government Services to Expand Reach of PoNS Therapy™
April 2, 2024
Helius Medical Technologies, Inc. Reports Fourth Quarter and Full Year 2023 Financial Results
March 27, 2024
Helius Medical Technologies, Inc. to Release Fourth Quarter and Full Year 2023 Financial Results on March 28, 2024
March 14, 2024
Helius Medical Technologies, Inc. Initiates Open-Label Study for Registrational Program in Stroke
March 11, 2024
Helius Medical Technologies, Inc. to Present at the 36th Annual ROTH Conference
March 6, 2024
Helius Medical Technologies, Inc. Secures HCPCS Codes for Portable Neuromodulation Stimulator (PoNS®) Mouthpiece and Controller
March 3, 2024
Helius Medical Technologies, Inc. Announces Alignment with FDA on Registrational Program for Treatment of Stroke Patients
February 5, 2024
Helius Booth and Special Event at APTA Combined Sections Meeting Will Highlight Physical Therapists’ Ability to Customize PoNS Therapy® to Improve Gait in People with MS
February 4, 2024
Helius Medical Technologies, Inc. Announces Further Expansion of Stroke Clinical Program with the Addition of Brooks Rehabilitation Hospital
January 10, 2024